Accumen's 3DR Labs partners with Resonance Health to expand its MR analysis services

Accumen's 3DR Labs partners with Resonance Health to expand its MR analysis services

Press releases may be edited for formatting or style | February 03, 2020 MRI
PHOENIX, AZ - FEBRUARY 3, 2020, Accumen Inc., the leader in healthcare performance, announced today that its 3DR Labs, LLC company is partnering with Resonance Health Limited (ASX: RHT) to provide FerriSmart magnetic resonance imaging- (MRI-) based liver iron concentration reports for its clients.

FerriSmart uses artificial intelligence (AI) to analyze MRI images and deliver a liver iron quantification result within seconds. This technology allows liver iron concentrations to be monitored effectively and efficiently for individuals with confirmed or suspected systemic iron overload, patients with thalassemia or sickle cell anemia who require regular blood transfusions, and recipients of artificial heart valves who may experience an increase in systemic iron levels over time.

"We are excited to partner with Resonance Health to provide our clients with this additional resource for mining valuable diagnostic data from their MRI images," said Accumen President and CEO Jeff Osborne. "3DR is already working with 900 hospitals in the United States, creating three-dimensional images from their MRI and computed tomography scans. We consider FerriSmart Reports to be a natural extension to the comprehensive MRI analysis services that we already offer to our 3DR clients."

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

"We are delighted to partner with 3DR Laboratories and significantly increase the number of patients who can benefit from our non-invasive, MRI-based FerriSmart technology. This important liver iron concentration information can provide invaluable insights and help to guide their treatment options," said Resonance Health CEO Alison Laws.

"Iron deposition disorders, such as sickle cell disease and thalassemia, are a significant health problem not only in the U.S. but worldwide. 3DR is thrilled to partner with Resonance Health in delivering a safer, easier and less expensive AI-based technology to help care for these patients," said 3DR Labs Chief Medical Officer Robert L Falk, MD.

Sickle cell disease is a group of inherited red blood cell disorders, characterized by hard, sticky, c-shaped red blood cells. These red blood cells die early, so they are always in short supply. They also tend to cause blood clots, which can result in pain, infection, acute chest syndrome and stroke.1 The US Centers for Disease Control and Prevention estimates that sickle cell disease affects approximately 100,000 Americans and millions of people throughout the world.2

You Must Be Logged In To Post A Comment